D.E. Shaw & Co’s Ingevity NGVT Stock Holding History

D.E. Shaw & Co’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,000	Closed	-$494K	–	4083
2020 Q3	$494K	Hold	10,000	–	–	﹤0.01%	3240
2020 Q2	$526K	Hold	10,000	–	–	﹤0.01%	3340
2020 Q1	$352K	Buy	+10,000	New	+$584K	﹤0.01%	3394

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

SCM

Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

D.E. Shaw & Co's NGVT Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Ingevity (NGVT) in Q1 2026, closing a stake of 21,862 shares — an estimated $1.29M sold.

D.E. Shaw & Co first reported a position in NGVT in Q2 2016 and held it in 32 quarters. The position peaked at $52.6M in Q1 2021. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

D.E. Shaw & Co reported no remaining Ingevity position as of Q1 2026 after selling out during the quarter.
D.E. Shaw & Co sold 21,862 Ingevity shares in Q1 2026, an estimated $1.29M.
D.E. Shaw & Co first reported a position in Ingevity in Q2 2016 and held it in 32 quarters.
D.E. Shaw & Co's Ingevity position peaked at $52.6M in Q1 2021.
307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.